LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...

Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a British global pharmaceutical and healthcare company that develops and markets a wide range of medicines, vaccines, and consumer health ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Teva Pharmaceutical Industries Ltd. ADR 0.46% $24.53B ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

GlaxoSmithKline (GSK) has accelerated the review of its Horlicks ... few bidders such as PepsiCo Inc and Reckitt Benckiser Group Plc. Reuters sources also list Nestlé, the world’s biggest ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Future PLC, ...

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...

Based on 11 Wall Street analysts offering 12 month price targets forGlaxoSmithKline PLC - Dist in the last 3 months.